These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 35184720)
1. Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population. Chathoth S; Ismail MH; Alghamdi HM; Zakaria HM; Hassan KA; Alshomimi S; Vatte C; Cyrus C; Alsaif HS; Mostafa A; Shaaban H; Al Ali A Lipids Health Dis; 2022 Feb; 21(1):24. PubMed ID: 35184720 [TBL] [Abstract][Full Text] [Related]
2. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach. Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217 [TBL] [Abstract][Full Text] [Related]
3. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Haus JM; Kashyap SR; Kasumov T; Zhang R; Kelly KR; Defronzo RA; Kirwan JP Diabetes; 2009 Feb; 58(2):337-43. PubMed ID: 19008343 [TBL] [Abstract][Full Text] [Related]
4. Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat. Fillmore N; Keung W; Kelly SE; Proctor SD; Lopaschuk GD; Ussher JR Exp Physiol; 2015 Jun; 100(6):730-41. PubMed ID: 25786668 [TBL] [Abstract][Full Text] [Related]
5. Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance. Blachnio-Zabielska AU; Koutsari C; Tchkonia T; Jensen MD Obesity (Silver Spring); 2012 Dec; 20(12):2341-7. PubMed ID: 22677645 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats. Campana M; Bellini L; Rouch C; Rachdi L; Coant N; Butin N; Bandet CL; Philippe E; Meneyrol K; Kassis N; Dairou J; Hajduch E; Colsch B; Magnan C; Le Stunff H Mol Metab; 2018 Feb; 8():23-36. PubMed ID: 29233519 [TBL] [Abstract][Full Text] [Related]
7. Gastric Bypass Surgery Improves the Skeletal Muscle Ceramide/S1P Ratio and Upregulates the AMPK/ SIRT1/ PGC-1α Pathway in Zucker Diabetic Fatty Rats. Huang H; Aminian A; Hassan M; Dan O; Axelrod CL; Schauer PR; Brethauer SA; Kirwan JP Obes Surg; 2019 Jul; 29(7):2158-2165. PubMed ID: 30809769 [TBL] [Abstract][Full Text] [Related]
8. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides. Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510 [TBL] [Abstract][Full Text] [Related]
9. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans. Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684 [TBL] [Abstract][Full Text] [Related]
10. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes. Lopez X; Goldfine AB; Holland WL; Gordillo R; Scherer PE J Pediatr Endocrinol Metab; 2013; 26(9-10):995-8. PubMed ID: 23612696 [TBL] [Abstract][Full Text] [Related]
11. Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans. Chung JO; Koutsari C; Blachnio-Zabielska AU; Hames KC; Jensen MD Diabetes; 2017 Aug; 66(8):2082-2091. PubMed ID: 28483801 [TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes. Broskey NT; Obanda DN; Burton JH; Cefalu WT; Ravussin E Metabolism; 2018 May; 82():118-123. PubMed ID: 29307520 [TBL] [Abstract][Full Text] [Related]
14. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694 [TBL] [Abstract][Full Text] [Related]
15. Fat-Secreted Ceramides Regulate Vascular Redox State and Influence Outcomes in Patients With Cardiovascular Disease. Akawi N; Checa A; Antonopoulos AS; Akoumianakis I; Daskalaki E; Kotanidis CP; Kondo H; Lee K; Yesilyurt D; Badi I; Polkinghorne M; Akbar N; Lundgren J; Chuaiphichai S; Choudhury R; Neubauer S; Channon KM; Torekov SS; Wheelock CE; Antoniades C J Am Coll Cardiol; 2021 May; 77(20):2494-2513. PubMed ID: 34016263 [TBL] [Abstract][Full Text] [Related]
16. Enhancing de novo ceramide synthesis induced by bisphenol A exposure aggravates metabolic derangement during obesity. Wang G; Hong X; Yu J; Zhang Y; Li Y; Li Z; Zhu Z; Yuan S; Zhang X; Wang S; Zhu F; Wang Y; Wu C; Su P; Shen T Mol Metab; 2023 Jul; 73():101741. PubMed ID: 37225016 [TBL] [Abstract][Full Text] [Related]
17. Sphingolipidomic profile and HDL subfractions in obese dyslipidemic type 2 diabetic patients. Aslan İ; Aydın D; Koca Y; Yılmaz Ç; Çeker T; Öztüzün A; Aslan M Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106719. PubMed ID: 36863606 [TBL] [Abstract][Full Text] [Related]
18. Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus. Kristensen D; Prats C; Larsen S; Ara I; Dela F; Helge JW Acta Diabetol; 2013 Oct; 50(5):705-12. PubMed ID: 22350135 [TBL] [Abstract][Full Text] [Related]